Immuno-Oncology Market Overview:

Cancer immunotherapy, also known as immuno-oncology, is a method of treating cancer by using the body's own immune system to stop, eliminate, and control the disease. It can also help you eliminate cancer by enhancing your immune system, providing additional components to your body to enhance the immune response, and educating your body to recognize and attack specific cancer cells. In cancer immunotherapy, a variety of therapies are available, such as targeted antibodies, cancer vaccines, adoptive cell transfer, tumor-infecting viruses, checkpoint inhibitors, cytokines, and adjuvants. Using substances from living organisms as a means to treat disease, immunotherapies are a form of biotherapy (also known as biologic therapy or biological response modifier (BRM) therapy). Gene therapy is one type of immunotherapy that uses genetic engineering to boost the immune cells' ability to fight cancer. 

The immune system of the human body is in charge of removing any foreign germs or viruses that enter the body, as they may infect the body with a disease or illness over time. Cancer cells are considered foreign bodies by the body's immune system, which eliminates them. Immuno-Oncology is a scientific endeavour by scientists to produce a cancer treatment that is effective. Immuno-Oncology is a process that involves concurrently detecting and measuring many analytes such as proteins, biomolecules, growth factors, cytokines, and chemokines. To target and destroy cancer cells, immuno-oncology primarily employs the body's natural defensive mechanism. This immuno-oncology is used to investigate the dynamic interactions between cancer cells and immune cells, the complex tumour microenvironment, detecting immunoreactivity in a variety of cell-based assays to predict mode of action, and pharmacodynamics. Furthermore, immuno-oncology has a lot of potential in drug development for disorders including cancer and cardiovascular diseases. The xMAP multiplex test, for example, provides a platform for cancer biomarker assays that may be performed on plasma, serum, cultured cells, and other biological samples. The immuno-oncology was created by the American Association of Cancer Research (AACR) to aid in the investigation of acquired resistance to receptor tyrosine kinase (RTK) inhibitors. RTK is a target for therapeutic development in the fight against cancer.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Immuno-Oncology Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Immuno-Oncology Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Immuno-Oncology Market:
• F. Hoffmann-La Roche AG
• Bristol-Myers Squibb
• Merck & Co., Inc.
• Novartis
• AstraZeneca Plc
• Pfizer Inc
• Eli Lilly and Company
• Johnson & Johnson
• Amgen Inc.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Immuno-Oncology Market Segmentation:
By Product Class
• Monoclonal Antibodies
 o Naked Monoclonal Antibodies
     o Rituxan (Rituximab)
     o Avastin (Bevacizumab)
     o Herceptin (Trastuzumab)
 o Conjugated Monoclonal Antibodies
     o ADCETRIS (Brentuximab vedotin)
     o Kadcyla (Ado-trastuzumab emtansine/TDM-1)
 o Bispecific Monoclonal Antibodies
     o Blincyto (Blinatumomab)
 o Others
• Therapeutic Vaccines
 o Provenge
• Immune Checkpoint Inhibitors
 o CTLA-4 Inhibitors (Cytotoxic T-lymphocyte-associated Protein-4)
     o Yervoy (Ipilimumab)
 o PD-1 and PD-L1 Inhibitors(Programmed Death 1 and Programmed Death Ligand
     o Opdivo (Nivolumab)
     o Keytruda (Pembrolizumab)
• Others
By Major Indications
• Head & Neck Cancer
• Lung Cancer
• Melanoma
• Lymphoma
• Leukemia
• Others

By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Immuno-Oncology Market Sample Video:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Immuno-Oncology Market By Product Class, By Major Indications and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics